News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
BB Biotech: Preliminary full-year 2024 results and dividend proposal
BB Biotech AG reports preliminary full-year 2024 results with a net profit of CHF 76 mn, proposing a dividend of CHF 1.80 per share at the AGM on March 19, 2025, focusing on shareholder returns and biotech sector growth -
-
-
-
COMMUNIQUÉ DE PRESSE
Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)
aap Implantate AG reports 6% annual sales growth, reaching EUR 12.2 million in 2024. Progress in all regions except the USA, with investments in new aap systems for future growth -